Compound preparation for treating cecal granuloma and preparation method thereof

A technology of cecal granuloma and compound preparations, which is applied to medical preparations with non-active ingredients, medical preparations containing active ingredients, and pharmaceutical formulas, can solve the problems of large human injuries, small side effects, and slow recovery, and achieve improved Immunity, drug side effects are small, and the effect of preventing intestinal obstruction

Inactive Publication Date: 2016-09-07
于爱华
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the main method of treating cecal granuloma is oral metronidazole and other drugs for treatment, but ileocecal schistosomiasis granuloma needs to be surgically removed to preven...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Embodiment 1: The present embodiment prepares a kind of compound oral liquid that is used for the treatment of cecal granuloma, comprises the composition of following parts by weight: 12 parts of chloroquine phosphate, 6 parts of chlorogenic acid, 8 parts of cistanche glycosides, 3 parts of ursolic acid, 3 parts of alfalfa, 2 parts of levamisole, 0.4 part of preservative, 8 parts of emulsifier, 2 parts of buffer, 3 parts of flavoring agent.

[0019] Wherein, the preservative is: methyl p-hydroxybenzoate. The preservative mainly protects the medicine from microbial contamination, prolongs the life of the product, and ensures the safety of the product; the emulsifier is: sodium dioctyl sulfosuccinate. The emulsifier mainly reduces the surface tension of the liquid and the solid, so that the liquid spreads rapidly to the entire surface and promotes the dispersion of the drug; the buffer is: nitrophosphate buffer; the buffer mainly prevents the pH of the liquid from changin...

Embodiment 2

[0023] Embodiment 2: present embodiment prepares a kind of compound oral liquid that is used for the treatment of cecal granuloma, comprises the composition of following parts by weight: 14.5 parts of chloroquine phosphate, 9 parts of chlorogenic acid, 10.5 parts of cistanche glycosides, 6 parts of ursolic acid, 5 parts of alfalfa, 3.5 parts of levamisole, 0.6 parts of preservative, 11.5 parts of emulsifier, 3.5 parts of buffer, 5 parts of flavoring agent.

[0024] Wherein, the preservative is: chlorocresol. The preservative mainly protects the medicine from microbial contamination, prolongs the life of the product, and ensures the safety of the product; the emulsifier is: sodium dioctyl sulfosuccinate. The emulsifier mainly reduces the surface tension of the liquid and the solid, so that the liquid spreads rapidly to the entire surface, and promotes the dispersion of the drug; the buffer is: citrate buffer. The buffer solution mainly prevents the pH of the liquid from changi...

Embodiment 3

[0028] Embodiment 3: present embodiment prepares a kind of compound oral liquid that is used for the treatment of cecal granuloma, comprises the composition of following parts by weight: 17 parts of chloroquine phosphate, 12 parts of chlorogenic acid, 13 parts of cistanche glycosides, 9 parts of ursolic acid, 7 parts of alfalfa, 5 parts of levamisole, 0.8 parts of preservative, 15 parts of emulsifier, 5 parts of buffer, 7 parts of flavoring agent.

[0029] Wherein, the preservative is: methyl p-hydroxybenzoate. The preservative mainly protects the medicine from microbial contamination, prolongs the life of the product, and ensures the safety of the product; the emulsifier is: sodium dioctyl sulfosuccinate. The emulsifier mainly reduces the surface tension of the liquid and the solid, so that the liquid spreads rapidly to the entire surface, and promotes the dispersion of the drug; the buffer is: amino acid buffer. The buffer solution mainly prevents the pH of the liquid from ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a compound preparation for treating cecal granuloma and a preparation method thereof. The compound preparation comprises chloroquine phosphate, diiodohydroxyquinoline, chlorogenic acid, liquiritin, cistanoside, ursolic acid, polysavone, levamisole, albendazole, okra powder, lactein, vitamin B1, lactalbumin and arginine. The compound preparation can effectively expand intestinal tubes, prevent intestinal obstruction, prevent mesentery and intestinal wall inflammatory infiltration and edema, prevent intestinal wall fibrosis, adjust body metabolism, improve immunity, reduce drug side effects and treat cecal granuloma and has a wide application prospect.

Description

technical field [0001] The invention relates to the technical field of medication for intestinal diseases, in particular to a compound preparation for treating cecal granuloma and a preparation method thereof. Background technique [0002] Cecal granuloma has cecal amebic granuloma and ileocecal schistosomiasis granuloma Cecal amebic granuloma is a complication of chronic colitis caused by histolytic amoeba E (Entamaeba Histolytica). Ileocecal schistosomiasis granuloma is a late-stage lesion of intestinal schistosomiasis, and the deposition site of schistosomiasis eggs is mainly in the terminal ileum except the colon. Can be complicated by diseases such as acute intestinal obstruction. [0003] Cecal amebic granuloma, due to long-term unhealed lesions, produces a large amount of fibrous tissue, inflammatory infiltration and edema of the mesentery and intestinal wall, forming a granuloma-like mass, and causing intestinal obstruction due to narrowing of the intestinal lumen o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/48A61K38/17A61P1/00A61P33/12A61P33/02A61K31/4706A61K31/216A61K31/7032A61K31/56A61K31/429A61K31/7048A61K31/47A61K35/747A61K31/51A61K31/198A61K31/4184
CPCA61K9/0053A61K9/08A61K31/198A61K31/216A61K31/4184A61K31/429A61K31/47A61K31/4706A61K31/51A61K31/56A61K31/7032A61K31/7048A61K35/747A61K36/185A61K36/48A61K38/1709A61K47/14A61K47/20A61K2300/00
Inventor 于爱华
Owner 于爱华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap